Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Future of SARS-CoV-2 Vaccination

Literature DB >> 34739199

The Future of SARS-CoV-2 Vaccination - Lessons from Influenza.

Arnold S Monto¹.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2021 PMID： 34739199 DOI： 10.1056/NEJMp2113403

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Containing novel SARS-CoV-2 variants at source is possible with high-intensity sequencing.

Authors: Tobias S Brett; Pejman Rohani
Journal: PNAS Nexus Date: 2022-08-19

2. The long and winding road leading to evidence-based medicine.

Authors: Edgardo Somigliana; Siladitya Bhattacharya
Journal: Hum Reprod Open Date: 2022-05-10

3. Primary COVID-19 vaccine cycle and booster doses efficacy: analysis of Italian nationwide vaccination campaign.

Authors: Camilla Mattiuzzi; Giuseppe Lippi
Journal: Eur J Public Health Date: 2022-04-01 Impact factor: 3.367

4. COVID-19 vaccination is highly effective to prevent SARS-CoV-2 circulation.

Authors: Camilla Mattiuzzi; Giuseppe Lippi
Journal: J Infect Public Health Date: 2022-03-12 Impact factor: 3.718

5. Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections.

Authors: Sara Terreri; Eva Piano Mortari; Maria Rosaria Vinci; Cristina Russo; Claudia Alteri; Christian Albano; Francesca Colavita; Giulia Gramigna; Chiara Agrati; Giulia Linardos; Luana Coltella; Luna Colagrossi; Gloria Deriu; Marta Ciofi Degli Atti; Caterina Rizzo; Marco Scarsella; Rita Brugaletta; Vincenzo Camisa; Annapaola Santoro; Giuseppe Roscilli; Emiliano Pavoni; Alessia Muzi; Nicola Magnavita; Rossana Scutari; Alberto Villani; Massimiliano Raponi; Franco Locatelli; Carlo Federico Perno; Salvatore Zaffina; Rita Carsetti
Journal: Cell Host Microbe Date: 2022-01-25 Impact factor: 21.023

The Future of SARS-CoV-2 Vaccination - Lessons from Influenza.

1. Containing novel SARS-CoV-2 variants at source is possible with high-intensity sequencing.

2. The long and winding road leading to evidence-based medicine.

3. Primary COVID-19 vaccine cycle and booster doses efficacy: analysis of Italian nationwide vaccination campaign.

4. COVID-19 vaccination is highly effective to prevent SARS-CoV-2 circulation.

5. Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections.

6. The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes.

7. COVID-19 vaccines, boosters and mandates: building a mission economy, not a rentier paradise.

Review 8. Understanding Vaccine Safety and the Roles of the FDA and the CDC.

Review 9. Recent insights into SARS-CoV-2 omicron variant.

10. Efficacy of COVID-19 vaccine booster doses in older people.